|
CH575014A5
(enExample)
|
1973-05-25 |
1976-04-30 |
Alusuisse |
|
|
JPS5328498Y2
(enExample)
|
1973-08-17 |
1978-07-18 |
|
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
BR9204244A
(pt)
|
1992-10-26 |
1994-05-03 |
Cofap |
Ferro fundido cinzento
|
|
EP0671951A4
(en)
|
1992-12-01 |
1997-05-21 |
Protein Design Labs Inc |
HUMANIZED ANTIBODIES REACTING WITH L-SELECTIN.
|
|
FR2729855A1
(fr)
|
1995-01-26 |
1996-08-02 |
Oreal |
Utilisation d'un antagoniste de cgrp dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
|
|
US5876950A
(en)
|
1995-01-26 |
1999-03-02 |
Bristol-Myers Squibb Company |
Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy
|
|
ATE283926T1
(de)
|
1995-09-11 |
2004-12-15 |
Kyowa Hakko Kogyo Kk |
Antikörper gegen die alpha-kette von humanem interleukin 5 rezeptor
|
|
EP0852951A1
(de)
|
1996-11-19 |
1998-07-15 |
Roche Diagnostics GmbH |
Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
|
|
CN1241944A
(zh)
|
1996-12-05 |
2000-01-19 |
乔治敦大学 |
具有抗病毒活性的鼠尾草种类的提取物
|
|
JPH11101542A
(ja)
|
1997-09-29 |
1999-04-13 |
Sanyo Electric Co Ltd |
冷蔵庫
|
|
DE69929183T2
(de)
|
1998-04-30 |
2006-08-24 |
Tanox, Inc., Houston |
G-csf-rezeptoragonist-antikörper und screeningverfahren dafür
|
|
FR2780062B1
(fr)
|
1998-06-17 |
2000-07-28 |
Rhone Poulenc Rorer Sa |
Anticorps monoclonaux diriges contre la proteine g3bp, et leurs utilisations
|
|
AU759689B2
(en)
|
1998-06-24 |
2003-04-17 |
Chugai Seiyaku Kabushiki Kaisha |
Novel hemopoietin receptor proteins
|
|
CA2342967A1
(en)
|
1998-12-08 |
2000-06-15 |
Biovation Limited |
Modifying protein immunogenicity
|
|
EP1188830B1
(en)
|
1999-06-02 |
2010-01-20 |
Chugai Seiyaku Kabushiki Kaisha |
Novel hemopoietin receptor protein ,nr10
|
|
WO2001023556A1
(en)
|
1999-09-27 |
2001-04-05 |
Chugai Seiyaku Kabushiki Kaisha |
Novel hemopoietin receptor protein, nr12
|
|
CN1326880A
(zh)
|
2000-06-06 |
2001-12-19 |
周伟中 |
双层站台火车站
|
|
US20030096339A1
(en)
|
2000-06-26 |
2003-05-22 |
Sprecher Cindy A. |
Cytokine receptor zcytor17
|
|
DK1325115T3
(en)
|
2000-06-26 |
2016-11-21 |
Zymogenetics Inc |
CYTOKINRECEPTOR ZCYTOR17
|
|
WO2002077230A1
(fr)
|
2001-03-26 |
2002-10-03 |
Chugai Seiyaku Kabushiki Kaisha |
Variants d'epissage nr10
|
|
RU2299888C2
(ru)
|
2001-04-05 |
2007-05-27 |
Иммуно-Байолоджикал Лэборэтэриз Ко., Лтд. |
Антитело против остеопонтина и его применение
|
|
JP4511349B2
(ja)
|
2002-01-18 |
2010-07-28 |
ザイモジェネティクス，インコーポレイティド |
サイトカイン受容体ｚｃｙｔｏｒ１７マルチマー
|
|
US7064186B2
(en)
|
2002-01-18 |
2006-06-20 |
Zymogenetics, Inc. |
Cytokine zcytor17 ligand
|
|
SI1485477T1
(sl)
|
2002-02-25 |
2009-10-31 |
Genentech Inc |
Novi citokinski receptor GLM-R tipa 1
|
|
AU2003225255B2
(en)
|
2002-05-01 |
2008-07-31 |
Bayer Schering Pharma Aktiengesellschaft |
Novel tissue factor targeted antibodies as anticoagulants
|
|
US7579000B2
(en)
|
2002-05-01 |
2009-08-25 |
Bayer Schering Pharma Ag |
Tissue factor targeted antibodies as anticoagulants
|
|
TW200407335A
(en)
|
2002-07-22 |
2004-05-16 |
Chugai Pharmaceutical Co Ltd |
Non-neutralizing antibody to inhibit the inactivation of activated protein C
|
|
KR100499989B1
(ko)
|
2002-12-27 |
2005-07-07 |
네오바이오다임 주식회사 |
아사이알로 α1-산 당단백질에 대한 단일클론 항체, 이 항체를 포함하는 아사이알로 α1-산 당단백질에 대한 단일클론 항체, 이 항체를 포함하는 면역크로마토그래피 스트립 및 이 스트립를 이용한 아사이알로 α1-산 당단백질 측정방법
|
|
US20040223970A1
(en)
|
2003-02-28 |
2004-11-11 |
Daniel Afar |
Antibodies against SLC15A2 and uses thereof
|
|
KR20050114224A
(ko)
|
2003-03-04 |
2005-12-05 |
알렉시온 파마슈티칼스, 인코포레이티드 |
항원 제공 세포의 내성을 유도함으로써 자가 면역 질환치료 방법
|
|
WO2004085476A2
(en)
|
2003-03-24 |
2004-10-07 |
Zymogenetics, Inc. |
Anti-il-22ra antibodies and binding partners and methods of using in inflammation
|
|
CA2555340A1
(en)
|
2004-02-12 |
2005-09-01 |
Lexicon Genetics Incorporated |
Gene disruptions, compositions and methods relating thereto
|
|
KR100624013B1
(ko)
|
2004-06-25 |
2006-09-19 |
주식회사 녹십자홀딩스 |
동결건조된 알부민 비함유 재조합 사람 혈액응고 제 8인자 제제
|
|
WO2006004663A2
(en)
|
2004-06-25 |
2006-01-12 |
Medimmune, Inc. |
Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis
|
|
EP1671642A1
(en)
|
2004-12-15 |
2006-06-21 |
Universite D'angers |
Compositions comprising (ant)agonists of oncostatin M (OSM), IL-31 and IFN-gamma for modulating keratinocyte migration and functions via a receptor containing OSMRbeta as a subunit, and applications thereof.
|
|
PT2476705E
(pt)
|
2004-12-28 |
2016-02-09 |
Innate Pharma |
Anticorpos monoclonais contra nkg2a
|
|
ES2579758T3
(es)
|
2005-01-28 |
2016-08-16 |
Zymogenetics, Inc. |
Preparaciones homogéneas de IL-31
|
|
CA2595877A1
(en)
|
2005-02-14 |
2006-08-24 |
Zymogenetics, Inc. |
Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
|
|
EP1858924A1
(en)
|
2005-02-14 |
2007-11-28 |
ZymoGenetics, Inc. |
Methods of treating skin disorders using an il-31ra antagonist
|
|
UY29504A1
(es)
|
2005-04-29 |
2006-10-31 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
|
|
US8003108B2
(en)
|
2005-05-03 |
2011-08-23 |
Amgen Inc. |
Sclerostin epitopes
|
|
WO2007143231A2
(en)
|
2006-01-10 |
2007-12-13 |
Zymogenetics, Inc. |
Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
|
|
KR101443050B1
(ko)
*
|
2005-05-06 |
2014-09-22 |
지모제넥틱스, 인코포레이티드 |
Ｉｌ-31 단클론성 항체 및 사용법
|
|
ES2709672T3
(es)
|
2006-01-12 |
2019-04-17 |
Alexion Pharma Inc |
Anticuerpos para OX-2/CD200 y usos de los mismos
|
|
HRP20110203T4
(hr)
|
2006-03-23 |
2014-05-09 |
Bioarctic Neuroscience Ab |
Poboljšana protutijela selektivna za protofibrile i njihova primjena
|
|
MX2008015568A
(es)
|
2006-06-08 |
2009-01-13 |
Chugai Pharmaceutical Co Ltd |
Agentes para prevenir o tratar enfermedades inflamatorias.
|
|
WO2007147122A2
(en)
|
2006-06-15 |
2007-12-21 |
The Board Of Trustees Of The University Of Arkansas |
Monoclonal antibodies that selectively recognize methamphetamine and methamphetamine like compounds
|
|
WO2008028192A2
(en)
|
2006-09-01 |
2008-03-06 |
Zymogenetics, Inc. |
Variable region sequences of il-31 monoclonal antibodies and methods of use
|
|
CN101600456A
(zh)
*
|
2006-12-11 |
2009-12-09 |
惠氏公司 |
治疗il-13相关疾病和监测il-13相关疾病治疗的方法和组合物
|
|
CA2672215A1
(en)
|
2006-12-11 |
2008-06-19 |
Wyeth |
Methods and compositions for treating and monitoring treatment of il-13-associated disorders
|
|
WO2008100995A1
(en)
|
2007-02-14 |
2008-08-21 |
Vaccinex, Inc. |
Humanized anti-cd100 antibodies
|
|
HRP20120611T1
(hr)
|
2007-02-23 |
2012-10-31 |
Schering Corporation |
Anti-il-23p19 antitijela proizvedena genetiäśkim inžinjerstvom
|
|
WO2008114733A1
(ja)
|
2007-03-16 |
2008-09-25 |
Kyowa Hakko Kirin Co., Ltd. |
抗Claudin-4抗体
|
|
GB0708002D0
(en)
|
2007-04-25 |
2007-06-06 |
Univ Sheffield |
Antibodies
|
|
WO2009007272A1
(en)
|
2007-07-10 |
2009-01-15 |
F. Hoffmann-La Roche Ag |
Novel formulation
|
|
CN101939425B
(zh)
|
2007-09-26 |
2014-05-14 |
中外制药株式会社 |
抗il-6受体抗体
|
|
MX336725B
(es)
|
2007-09-26 |
2016-01-28 |
Chugai Pharmaceutical Co Ltd |
Metodo de modificacion del punto isoelectrico de anticuerpos medinate la sustitucion de aminoacidos en region de determinacion de complementariedad (cdr).
|
|
RU2526512C2
(ru)
|
2007-09-26 |
2014-08-20 |
Чугаи Сейяку Кабусики Кайся |
Модифицированная константная область антитела
|
|
TWI441649B
(zh)
|
2007-12-05 |
2014-06-21 |
Chugai Pharmaceutical Co Ltd |
Use of anti-NR10 monoclonal antibody with neutralizing activity against NR10 in the manufacture of prophylactic or therapeutic agents for pruritus
|
|
MY177564A
(en)
|
2007-12-05 |
2020-09-20 |
Chugai Pharmaceutical Co Ltd |
Anti-nr10 antibody and use thereof
|
|
CA2708251C
(en)
|
2007-12-07 |
2016-04-12 |
Zymogenetics, Inc. |
Humanized antibody molecules specific for il-31
|
|
KR20160062207A
(ko)
*
|
2008-12-05 |
2016-06-01 |
추가이 세이야쿠 가부시키가이샤 |
항ｎｒ１０ 항체 및 그의 이용
|
|
JP2010210772A
(ja)
*
|
2009-03-13 |
2010-09-24 |
Dainippon Screen Mfg Co Ltd |
液晶表示装置の製造方法
|
|
ES2569514T3
(es)
|
2009-06-17 |
2016-05-11 |
Biomarin Pharmaceutical Inc. |
Formulaciones para enzimas lisosómicas
|
|
EP2735315B1
(en)
|
2011-07-19 |
2019-10-02 |
Chugai Seiyaku Kabushiki Kaisha |
Stable protein-containing preparation containing argininamide or valinamide
|
|
US8790651B2
(en)
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
|
ES2981062T3
(es)
|
2012-09-07 |
2024-10-07 |
Regeneron Pharma |
Métodos para el tratamiento de la dermatitis atópica administrando un antagonista de IL-4R
|
|
US9198898B2
(en)
*
|
2013-06-24 |
2015-12-01 |
Tigercat Pharma, Inc. |
Use of NK-1 receptor antagonists in pruritus
|
|
JP5650871B1
(ja)
*
|
2013-06-28 |
2015-01-07 |
中外製薬株式会社 |
そう痒を伴う疾患に罹患した患者のｉｌ−３１アンタゴニストによる治療に対する応答を予測する方法
|
|
CA2980992C
(en)
|
2015-04-14 |
2024-01-23 |
Akihisa Kaneko |
Pharmaceutical composition for prevention and/or treatment of atopic dermatitis containing il-31 antagonist as active ingredient
|
|
GB201703063D0
(en)
|
2017-02-24 |
2017-04-12 |
Arecor Ltd |
Stabilized antibody protein solutions
|
|
WO2018156367A1
(en)
|
2017-02-24 |
2018-08-30 |
Kindred Biosciences, Inc. |
Anti-il31 antibodies for veterinary use
|
|
AU2018251808B2
(en)
|
2017-04-11 |
2025-04-10 |
Kiniksa Pharmaceuticals, Ltd. |
Stable anti-OSMR antibody formulation
|
|
TWI840360B
(zh)
|
2018-05-21 |
2024-05-01 |
日商中外製藥股份有限公司 |
密封於玻璃容器之凍結乾燥的製劑、套組、製造凍結乾燥製劑的方法、防止或減低凍結乾燥製劑的玻璃容器成霧的方法、及容器內面經過硫酸銨處理或ｖｉｓｔ處理之玻璃容器
|
|
CA3156713A1
(en)
|
2019-11-20 |
2021-05-27 |
Daisuke Kameoka |
Antibody-containing preparation
|
|
KR102800698B1
(ko)
|
2020-09-01 |
2025-04-24 |
추가이 세이야쿠 가부시키가이샤 |
Il-31 안타고니스트를 유효 성분으로서 함유하는, 투석 소양증의 예방용 및/또는 치료용 의약 조성물
|